As of 2025-08-06, the EV/EBITDA ratio of Selecta Biosciences Inc (SELB) is -1.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SELB's latest enterprise value is 47.20 mil USD. SELB's TTM EBITDA according to its financial statements is -36.19 mil USD. Dividing these 2 quantities gives us the above SELB EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 13.3x | 10.8x |
| Forward P/E multiples | 12.4x - 20.7x | 16.6x |
| Fair Price | (1.36) - 1.49 | (0.33) |
| Upside | -254.4% - 69.6% | -137.0% |
| Date | EV/EBITDA |